Katharine Bray‐French

CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study

Philippe A. Cassier, Antoîne Italiano, Carlos Gomez-Roca et al. · The Lancet Oncology · 2015 · 356 citations

Medicine, Immunology, Pathology +9

CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies

Marina Bacac, Sara Colombetti, Sylvia Herter et al. · Clinical Cancer Research · 2018 · 223 citations

The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia

Robert Dallmann, Philipp Weyermann, Corinne Anklin et al. · Journal of Cachexia Sarcopenia and Muscle · 2011 · 55 citations · Full text

Palladium-Catalyzed Cross-Coupling Reactions for the Synthesis of 6,8-Disubstituted 1,7-Naphthyridines:  A Novel Class of Potent and Selective Phosphodiesterase Type 4D Inhibitors

René Hersperger, Katharine Bray‐French, Lazzaro Mazzoni et al. · Journal of Medicinal Chemistry · 2000 · 54 citations · Full text

Pharmaceutical Science, Palladium-catalyzed Cross-coupling Reactions, Organic Chemistry +20

Application of a MABEL Approach for a T-Cell-Bispecific Monoclonal Antibody: CEA TCB

Sherri Dudal, Heather Hinton, Anna Maria Giusti et al. · Journal of Immunotherapy · 2016 · 39 citations

Immunocytochemical Technique, T-cell-bispecific Monoclonal Antibody, Immunology +24